Comparable Relapse Incidence after Unrelated Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Conventional Anti-Graft Versus Host Disease Prophylaxis in Patients with Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation